Cargando…

Oestrogen receptor pathway activity is associated with outcome in endometrial cancer

BACKGROUND: Oestrogen receptor (ER) expression is a prognostic biomarker in endometrial cancer (EC). However, expression does not provide information about the functional activity of the ER pathway. We evaluated a model to quantify ER pathway activity in EC, and determined the prognostic relevance o...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Weelden, Willem Jan, van der Putten, Louis J. M., Inda, Márcia A., van Brussel, Anne, Snijders, Marc P. L. M., Schriever, Lisanne M. M., Bulten, Johan, Massuger, Leon F. A. G., van de Stolpe, Anja, Pijnenborg, Johanna M. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463017/ https://www.ncbi.nlm.nih.gov/pubmed/32507853 http://dx.doi.org/10.1038/s41416-020-0925-4

Ejemplares similares

Anti-estrogen Treatment in Endometrial Cancer: A Systematic Review
por: van Weelden, Willem Jan, et al.
Publicado: (2019)

Tissue microarray is suitable for scientific biomarkers studies in endometrial cancer
por: Visser, Nicole C. M., et al.
Publicado: (2018)

Reproducibility of measurement of myometrial invasion in endometrial carcinoma
por: van der Putten, Louis J. M., et al.
Publicado: (2016)

L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial Carcinoma
por: Geels, Yvette P., et al.
Publicado: (2016)

Improved preoperative risk stratification with CA-125 in low-grade endometrial cancer: a multicenter prospective cohort study
por: Reijnen, Casper, et al.
Publicado: (2019)

Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: a retrospective study
por: van Weelden, Willem Jan, et al.
Publicado: (2019)

Recurrent Endometrial Cancer: Local and Systemic Treatment Options
por: Rütten, Heidi, et al.
Publicado: (2021)

Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer
por: Vrede, Stephanie W., et al.
Publicado: (2022)

Long‐term risk of endometrial cancer following postmenopausal bleeding and reassuring endometrial biopsy
por: Visser, Nicole C.M., et al.
Publicado: (2016)

Poor outcome in hypoxic endometrial carcinoma is related to vascular density
por: Reijnen, Casper, et al.
Publicado: (2019)

Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome
por: Reijnen, Casper, et al.
Publicado: (2020)

PIpelle Prospective ENDOmetrial carcinoma (PIPENDO) study, pre-operative recognition of high risk endometrial carcinoma: a multicentre prospective cohort study
por: Visser, Nicole C. M., et al.
Publicado: (2015)

Heterogeneity in Signaling Pathway Activity within Primary and between Primary and Metastatic Breast Cancer
por: Inda, Márcia A., et al.
Publicado: (2021)

Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms
por: van Weelden, Geert, et al.
Publicado: (2019)

L1CAM expression in endometrial carcinomas: an ENITEC collaboration study
por: van der Putten, Louis JM, et al.
Publicado: (2016)

The effect of progestin therapy in advanced and recurrent endometrial cancer: A systematic review and meta‐analysis
por: van Weelden, Willem Jan, et al.
Publicado: (2022)

The impact of adipose tissue distribution on endometrial cancer: a systematic review
por: van den Bosch, Anouk A. S., et al.
Publicado: (2023)

Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study
por: Reijnen, Casper, et al.
Publicado: (2020)

Enabling precision medicine by unravelling disease pathophysiology: quantifying signal transduction pathway activity across cell and tissue types
por: Stolpe, Anja van de, et al.
Publicado: (2019)

Publisher Correction: Enabling precision medicine by unravelling disease pathophysiology: quantifying signal transduction pathway activity across cell and tissue types
por: van de Stolpe, Anja, et al.
Publicado: (2020)

Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders
por: Gibson, Douglas A., et al.
Publicado: (2018)

Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancer
por: van Bommel, Majke H.D., et al.
Publicado: (2022)

ER and PI3K Pathway Activity in Primary ER Positive Breast Cancer Is Associated with Progression-Free Survival of Metastatic Patients under First-Line Tamoxifen
por: M. Sieuwerts, Anieta, et al.
Publicado: (2020)

Endometrial Cancer Incidence in Endometriosis and Adenomyosis
por: Hermens, Marjolein, et al.
Publicado: (2021)

Gene Promoter Methylation in Endometrial Carcinogenesis
por: Cornel, Karlijn M. C., et al.
Publicado: (2018)

Pure and mixed clear cell carcinoma of the endometrium: A molecular and immunohistochemical analysis study
por: Reijnen, Casper, et al.
Publicado: (2023)

Hemoglobin level predicts outcome for vulvar cancer patients independent of GLUT-1 and CA-IX expression in tumor tissue
por: van de Nieuwenhof, Hedwig P., et al.
Publicado: (2010)

Limited independent prognostic value of MMP-14 and MMP-2 expression in ovarian cancer
por: Vos, M. Caroline, et al.
Publicado: (2016)

Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome
por: Gerritzen, Lotte H. M., et al.
Publicado: (2009)

Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004–2013
por: van der Horst, Judith, et al.
Publicado: (2017)

Endometrial cancer prognosis in women with endometriosis and adenomyosis: A retrospective nationwide cohort study of 40 840 women
por: Hermens, Marjolein, et al.
Publicado: (2021)

Intra-tumoural variation of oestrogen receptor status in endometrial cancer.
por: Castagnetta, L., et al.
Publicado: (1983)

Primary Ovarian Carcinomas and Abdominal Metastasis Contain 4,6-Disulfated Chondroitin Sulfate Rich Regions, Which Provide Adhesive Properties to Tumour Cells
por: Vallen, Myrtille J. E., et al.
Publicado: (2014)

Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial Cancer
por: Lombaers, Marike S., et al.
Publicado: (2023)

Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study
por: Zeleniuch-Jacquotte, A, et al.
Publicado: (2001)

Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas
por: Reich, O, et al.
Publicado: (2000)

Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
por: Vermij, Lisa, et al.
Publicado: (2023)

Altered endometrial oestrogen-responsiveness and recurrent reproductive failure
por: Al-Lamee, Hannan, et al.
Publicado: (2022)

The role of fat distribution and inflammation in the origin of endometrial cancer, study protocol of the ENDOCRINE study
por: van den Bosch, A. A. S., et al.
Publicado: (2022)

CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer
por: van Agthoven, T, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_fu0b7dcosna2asnv7gbsn56htf